We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COST icon
451
Costco
COST
$420B
$6.52M 0.04%
31,211
-121,523
-80% -$24M
LPLA icon
452
LPL Financial
LPLA
$28.6B
$6.48M 0.04%
98,848
-730,822
-88% -$48M
ICUI icon
453
ICU Medical
ICUI
$4.61B
$6.44M 0.04%
21,920
+18,595
+559% +$5.08M
CRL icon
454
Charles River Laboratories
CRL
$12.8B
$6.43M 0.04%
+57,307
New +$6.2M
SUM
455
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$6.37M 0.04%
246,834
-152,242
-38% -$4.24M
NVT icon
456
nVent Electric
NVT
$26.7B
$6.35M 0.04%
+252,905
New +$6.58M
ISBC
457
DELISTED
Investors Bancorp, Inc.
ISBC
$6.3M 0.04%
+492,632
New +$6.64M
GNW icon
458
Genworth Financial
GNW
$3.71B
$6.29M 0.04%
1,398,839
-1,113,159
-44% -$3.84M
WTFC icon
459
Wintrust Financial
WTFC
$10.7B
$6.29M 0.04%
+72,303
New +$6.64M
KMT icon
460
Kennametal
KMT
$2.52B
$6.27M 0.04%
174,577
+113,146
+184% +$4.35M
NGG icon
461
National Grid
NGG
$81.3B
$6.25M 0.04%
+126,561
New +$6.39M
CLF icon
462
Cleveland-Cliffs
CLF
$6.99B
$6.25M 0.04%
741,407
-2,018,076
-73% -$16.1M
VOYA icon
463
Voya Financial
VOYA
$9.19B
$6.25M 0.04%
132,917
-320,300
-71% -$16.6M
MITL
464
DELISTED
Mitel Networks Corporation
MITL
$6.23M 0.04%
567,882
+258,789
+84% +$2.77M
CNI icon
465
Canadian National Railway
CNI
$76.6B
$6.15M 0.03%
75,257
-123,553
-62% -$9.82M
ENB icon
466
Enbridge
ENB
$112B
$6.11M 0.03%
171,046
+142,446
+498% +$4.51M
KRO icon
467
KRONOS Worldwide
KRO
$989M
$6.09M 0.03%
270,292
-14,236
-5% -$339K
HRTX icon
468
Heron Therapeutics
HRTX
$92.9M
$6.07M 0.03%
+156,298
New +$4.98M
CLSD
469
DELISTED
Clearside Biomedical
CLSD
$6.06M 0.03%
37,781
-19,337
-34% -$3.26M
TSC
470
DELISTED
TriState Capital Holdings, Inc.
TSC
$6.05M 0.03%
231,771
+222,203
+2,322% +$5.63M
EMBJ
471
Embraer S.A. ADS
EMBJ
$13B
$6.02M 0.03%
+241,832
New +$6.15M
VCRA
472
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$6.01M 0.03%
+201,254
New +$5.34M
GBT
473
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.98M 0.03%
+132,283
New +$6.02M
EQM
474
DELISTED
EQM Midstream Partners, LP
EQM
$5.91M 0.03%
+114,528
New +$6.48M
CIT
475
DELISTED
CIT Group Inc.
CIT
$5.88M 0.03%
+116,712
New +$6.09M
17 18
19
20 21

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.